Back
Zevra Therapeutics Stock Price Chart
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Buy
52
ZVRA
Zevra Therapeutics
Last Price:
8.00
Seasonality Move:
-17.07%
7 Day Trial
ALL ACCESS PASS
$
7
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pm- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZVRA is experiencing slight buying pressure.
Zevra Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.56 | Buy |
| 20-day SMA: | 7.4 | Buy |
| 50-day SMA: | 6.92 | Buy |
| 200-day SMA: | 5.74 | Buy |
| 8-day EMA: | 7.6 | Buy |
| 20-day EMA: | 7.4 | Buy |
| 50-day EMA: | 6.86 | Buy |
| 200-day EMA: | 5.85 | Buy |
Zevra Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.24 | Buy |
| Relative Strength Index (14 RSI): | 60.91 | Buy |
| Chaikin Money Flow: | 82002 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.13 - 7.61) | Buy |
| Bollinger Bands (100): | (4.6 - 7.02) | Buy |
Zevra Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Zevra Therapeutics Stock
Is Zevra Therapeutics Stock a Buy?
- Zevra Therapeutics share price is 7.83 while ZVRA 8-day simple moving average is 7.56, which is a Buy signal.
- The stock price of ZVRA is 7.83 while Zevra Therapeutics 20-day SMA is 7.40, which makes it a Buy.
- Zevra Therapeutics 50-day simple moving average is 6.92 while ZVRA share price is 7.83, making it a Buy technically.
- ZVRA stock price is 7.83 and Zevra Therapeutics 200-day simple moving average is 5.74, creating a Buy signal.
ZVRA Technical Analysis vs Fundamental Analysis
Buy
52
Zevra Therapeutics (ZVRA)
is a Buy
Is Zevra Therapeutics a Buy or a Sell?
-
Zevra Therapeutics stock is rated a Buy
The current Zevra Therapeutics [ZVRA] share price is $7.83. The Score for ZVRA is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
Zevra Therapeutics Stock Info
Market Cap:
412M
Price in USD:
7.83
Share Volume:
1M
Zevra Therapeutics 52-Week Range
52-Week High:
8.44
52-Week Low:
3.89
Buy
52
Zevra Therapeutics (ZVRA)
is a Buy
Zevra Therapeutics Share Price Forecast
-
What is the Zevra Therapeutics stock price today?
The Zevra Therapeutics stock price is 7.83 USD today. -
Will ZVRA stock go up or go down?
Zevra Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Zevra Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Zevra Therapeutics is not overvalued.
Is Zevra Therapeutics Stock a Buy?
- Zevra Therapeutics share price is 7.83 while ZVRA 8-day exponential moving average is 7.60, which is a Buy signal.
- The stock price of ZVRA is 7.83 while Zevra Therapeutics 20-day EMA is 7.40, which makes it a Buy.
- Zevra Therapeutics 50-day exponential moving average is 6.86 while ZVRA share price is 7.83, making it a Buy technically.
- ZVRA stock price is 7.83 and Zevra Therapeutics 200-day simple moving average is 5.85, creating a Buy signal.
Fundamental Analysis of Zevra Therapeutics
Is Zevra Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.29 per share, a decrease this year of $0.35 per share, and an increase next year of $1.14 per share.
Technical Analysis of Zevra Therapeutics
Should I short Zevra Therapeutics stock?
- ZVRA Moving Average Covergence Divergence (MACD) indicator is 0.24, suggesting Zevra Therapeutics is a Buy
- Zevra Therapeutics Relative Strength Index (RSI) is 60.91, which suggest Zevra Therapeutics is overbought
- The Bollinger Bands (25) for Zevra Therapeutics is (7.13 - 7.61), which suggest Zevra Therapeutics is a Buy
- The Bollinger Bands (100) for Zevra Therapeutics is (4.6 - 7.02), which suggest Zevra Therapeutics is a Buy
* Zevra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.